Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

BACKGROUND: The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients at early stages of the disease are of high clinical relev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Djureinovic, Dijana, Pontén, Victor, Landelius, Per, Al Sayegh, Sahar, Kappert, Kai, Kamali-Moghaddam, Masood, Micke, Patrick, Ståhle, Elisabeth
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664554/
https://ncbi.nlm.nih.gov/pubmed/31357969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5943-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars